I believe $CRSP Crisper Technologies to be a high-risk, high-reward investment as they continue developing genome-editing technology. They've demonstrated profound effectiveness with >90% cure rates for B-thalassemia and sickle cell. https://t.co/jOdHPy
647 followers
1,015 followers
43 followers
Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research #CRISPR #Science #MedTwitter #Cardiology #cardiovascular https://t.co/nw43GYMLjI
1,754 followers
REVIEW "Recent advances in #CRISPR-based genome editing technology and its applications in cardiovascular research" Li ZH, Wang J, Xu JP, Wang J, Yang X. Military Medical Research. 2023-03-10. (15 pages/195 references) https://t.co/uQL7q6WfqS